11/14/2024
3:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
6:12 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024
3:37 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
3:58 PM | DeFrancesco Lisa (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2024
5:51 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
11:15 PM | Lexicon Pharmaceuticals (Filer)
| Form EFFECT | |
08/15/2024
3:47 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/12/2024
7:39 AM | Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
7:40 AM | Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
8:37 AM | Lexicon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/02/2024
6:06 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
4:44 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/29/2024
4:31 PM | Invus Global Management, LLC (Reporting)
Lexicon Pharmaceuticals (Issuer)
Siren, L.L.C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
9:10 AM | FMR LLC (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G | |
07/08/2024
4:26 PM | Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
4:27 PM | Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:27 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
8:15 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
11:15 PM | Lexicon Pharmaceuticals (Filer)
| Form EFFECT | |
05/14/2024
4:17 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:00 PM | Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:01 PM | BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:02 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:03 PM | LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
4:14 PM | Lexicon Pharmaceuticals (Filer)
| Form S-3/A | |
04/29/2024
3:16 PM | Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:17 PM | BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:17 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:18 PM | LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:20 PM | Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:21 PM | Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
8:00 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:05 PM | Lexicon Pharmaceuticals (Filer)
| Form ARS | |
03/26/2024
6:05 AM | Lexicon Pharmaceuticals (Filer)
| Form DEF 14A | |
03/26/2024
6:06 AM | Lexicon Pharmaceuticals (Filer)
| Form DEFA14A | |
03/25/2024
3:17 PM | Lexicon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/13/2024
8:20 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/13/2024
8:22 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:31 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
6:26 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:31 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
02/29/2024
3:32 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:37 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
4:27 PM | Lexicon Pharmaceuticals (Filer)
| Form 424B5 | |
12/29/2023
4:29 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:55 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
